Delivery Order SPE2DB22D1106-SPE2DB23FEHT6

Award Date 5/15/23
Potential Completion Date 5/16/23
Potential Value $36K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $31,417.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, valued at $1,194.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical commodity used for the emergency treatment of severe allergic reactions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award, valued at $8,464.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 4,562,581,703 units of Epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award, with a ceiling value of $13,021.31, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg Auto-Injectors, which are critical medical supplies used for the treatment of severe allergic reactions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
This federal contract award, valued at $4,268.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medication used for the emergency treatment of severe allergic reactions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, valued at $3,588.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Epinephrine 0.15 mg auto-injectors, which are critical medical supplies used to treat severe allergic reactions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support...
This contract award, valued at $14,298.42, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of epinephrine 0.3 mg auto-injectors, a critical medical product used to treat anaphylaxis. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,468.60 delivery order covers the supply of Epinephrine 0.3 mg auto-injectors, a critical medication for emergency medical care. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,513.70 delivery order is for the supply of Epinephrine 0.3 mg auto-injectors, a critical medical commodity used for the treatment of severe allergic reactions. The contract has a period of performance through December 28, 2023 and is a firm-fixed price delivery order. This award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $1,840.56, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.15 mg auto-injectors and has an ultimate completion date of July 20, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB23FEHT6
    Delivery Order

This federal contract award, valued at $36,083.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical product used for emergency treatment of severe allergic reactions.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing structure and does not utilize any set-aside designations, indicating open competition.

Generated 5/9/25, 9:56 AM